Reversal of ongoing rejection of allografts by rapamycin.
Chen
H F
HF
Laboratory of Surgical Research, Hospital Notre-Dame, University of Montreal, Quebec, Canada.
Wu
J P
JP
Luo
H Y
HY
Daloze
P M
PM
D000818:Animals; D004386:Duodenum / Q000473:pathology / Q000637:transplantation; D006084:Graft Rejection / Q000187:drug effects*; D016027:Heart Transplantation / Q000276:immunology* / Q000473:pathology; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology; D008297:Male; D016035:Pancreas Transplantation / Q000276:immunology* / Q000473:pathology; D011090:Polyenes / Q000627:therapeutic use*; D051381:Rats; D011915:Rats, Inbred BUF; D011920:Rats, Inbred WF; D020123:Sirolimus; D016042:Transplantation, Heterotopic; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D011090:Polyenes; D020123:Sirolimus